Overall Technical outlook

Price Summary

Zydus Lifesciences Limited's stock opened at 1014.5 on 2025-09-04, surged to 1017.4, dropped to 1002.5, and ended -0.25% lower at 1011.95, with 1037917 shares traded.
Over the course of 52 weeks, the stock peaked at 1120.1 and hit a low of 822.1.
30 analysts forecast that the price of ZYDUSLIFE will range from 794.0 to 1150.0, with an average expected price near 970.1.

Technicals

Support and Resistance: The current price sits at 1011.95, supported at 978.8 and capped by resistance at 1023.15. These levels define a range for ZYDUSLIFE where the price might stabilize, with 978.8 as a floor and 1023.15 as a ceiling.
ZYDUSLIFE supportResistance 79bf5f
Support/Resistance for ZYDUSLIFE


Aroon: The AROON is showing a neutral reading, with no clear direction indicated for upward or downward movement. This neutral position suggests a possible period of consolidation.
ZYDUSLIFE aroon 79bf5f
Aroon chart for Zydus Lifesciences Limited


Bol. Bands: The current reading of the BOLL BANDS is neutral, offering no clear signals for a movement in either direction. This suggests that the market may be in a holding pattern, with no dominant trend in place.
ZYDUSLIFE bbands 79bf5f
Bolinger Bands chart for Zydus Lifesciences Limited


Parabolic SAR: The PSAR maintains its bullish stance, setting a significant support level that could help maintain the market's upward movement. This strong support suggests that the market is poised to continue its positive trend, providing confidence in the ongoing bullish momentum.
ZYDUSLIFE psar 79bf5f
Parabolic Stop and Reverse chart for Zydus Lifesciences Limited


Stochastic: The current state of the STOCHASTIC is neutral for ZYDUSLIFE, providing no clear indication of a trend in either direction. This suggests that the market may be lacking momentum, making it difficult to predict future movements.
ZYDUSLIFE stoch 79bf5f
Stochastic chart for Zydus Lifesciences Limited


Tripple Moving Agerage: The 20, 50, and 100 moving averages for Zydus Lifesciences Limited are currently aligned in a bearish formation, signaling a downtrend. However, the wavering slopes of the 20 and 50 SMAs suggest that this bearish momentum may be weakening. This could indicate an upcoming shift towards bullish price action, as the loss of downward momentum might lead to a potential reversal in the market's current trend.
ZYDUSLIFE trippleSMA 79bf5f
Tripple SMA chart for Zydus Lifesciences Limited


To derive valuable insights from a company's technical performance, it is essential to first understand its fundamentals. This includes its financial health, business model, and market share. Equally important is the industry context, such as competition, consumer demand, and market trends. By examining these aspects together, investors can gain a more comprehensive view of how the company's stock behaves and whether it's aligned with its underlying value.